Document Detail

APE1 and XRCC3 polymorphisms and myocardial infarction.
MedLine Citation:
PMID:  18712175     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: In most cells, DNA is regularly damaged by mutagens. Different DNA repair mechanisms operate on specific types of damaged DNA. When DNA damage resulting from free radicals is not repaired, it might lead to deteriorated gene expression, the development of a number of diseases such as cancer, diabetes, vascular diseases, and aging. In the present study, APE1 and XRCC3 gene polymorphisms were investigated in patients with myocardial infarction. MATERIALS AND METHODS: Forty-five first time elective coronary artery bypass grafting (CABG) patients with cardiopulmonary bypass (CPB) and 40 healthy individuals were studied. Gene polymorphisms were determined by a polymerase chain reaction-restriction fragment length polymorphism method. RESULTS: For the APE1 gene, the AG genotype was significantly higher in the patient group than in the control group. The patient group had significantly more G carriers but there was no statistically significant difference between patient and control groups the A allele. The XRCC3 TT genotype was found to be significantly more frequent in the patient group than it was in the control group. CONCLUSION: The results of our study suggested that the XRCC3 gene TT genotype and the APE1 gene AG genotype might increase the risk of myocardial infarcts.
Atike Tekeli; Selim Isbir; Arzu Ergen; Uzay Görmüş; Nilüfer Bozkurt; Ozlem Timirci; Sinan Arsan; Turgay Isbir
Related Documents :
14572165 - Combined oral contraceptives and the risk of myocardial infarction.
3321985 - Atherosclerosis and its evolution in childhood.
22050785 - Natural history of prenatal ventricular septal defects and their association with foeta...
14976845 - Is obesity still a risk factor for patients undergoing coronary surgery?
7621315 - Evidence of residual ischaemia: real danger or myth?
17302725 - Placement of a pacing lead at the inferior portion of the interatrial septum without sp...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  In vivo (Athens, Greece)     Volume:  22     ISSN:  0258-851X     ISO Abbreviation:  In Vivo     Publication Date:    2008 Jul-Aug
Date Detail:
Created Date:  2008-08-20     Completed Date:  2008-09-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8806809     Medline TA:  In Vivo     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  477-9     Citation Subset:  IM    
Department of Molecular Medicine, The Institute of Experimental Medicine, Istanbul University, Capa-Istanbul, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Case-Control Studies
Coronary Artery Bypass
DNA Primers / chemistry
DNA Repair
DNA-(Apurinic or Apyrimidinic Site) Lyase / genetics*,  physiology*
DNA-Binding Proteins / genetics*,  physiology*
Myocardial Infarction / genetics*,  pathology*
Polymorphism, Genetic*
Reg. No./Substance:
0/DNA Primers; 0/DNA-Binding Proteins; 0/X-ray repair cross complementing protein 3; EC protein, human; EC or Apyrimidinic Site) Lyase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antiviral, antibacterial and vitamin C-synergized radical-scavenging activity of Sasa senanensis Reh...
Next Document:  Interleukin-2 inhalation therapy in renal cell cancer: a case report and review of the literature.